Bogen B, Snodgrass R, Briand J P, Hannestad K
Eur J Immunol. 1986 Nov;16(11):1379-84. doi: 10.1002/eji.1830161111.
Twelve L3T4+ Ly-2.2- subclones, derived from 4 independent BALB/c T cell lines, responded to a combination of the I-Ed molecule and a synthetic peptide corresponding to residues 91-108 of the lambda light chain from BALB/c myeloma protein M315 (alpha, lambda 2). Peptide analogues in which the mutated residues Arg95 or Asn96 were exchanged with the corresponding germ-line-encoded Ser95 or Thr96 had an abolished or greatly reduced capacity to stimulate T cell clones. However, responses of subclones to an analogue where the mutated Phe94 was substituted with the germ-line-encoded Tyr94 revealed three specificity patterns: 5 clones reacted only with the lambda 2(315) peptide, 6 clones responded equally well to both peptides and a single clone reacted better with the Tyr94 analogue. Analysis of the T cell receptor beta-chain gene rearrangements disclosed 7 distinct rearrangements, identical rearrangements only being found for subclones originating from the same line. At least 3 different V beta genes were used. Subclones with identical or nearly identical peptide specificity, major histocompatibility complex-restriction and alloreactivity could differ in their V beta or J beta gene segment utilization.
从4个独立的BALB/c T细胞系衍生而来的12个L3T4+Ly-2.2-亚克隆,对I-Ed分子与对应于BALB/c骨髓瘤蛋白M315(α,λ2)λ轻链91-108位残基的合成肽的组合有反应。其中突变残基Arg95或Asn96被种系编码的Ser95或Thr96替换的肽类似物刺激T细胞克隆的能力被消除或大大降低。然而,亚克隆对突变的Phe94被种系编码的Tyr94取代的类似物的反应揭示了三种特异性模式:5个克隆仅与λ2(315)肽反应,6个克隆对两种肽的反应同样良好,单个克隆对Tyr94类似物反应更好。对T细胞受体β链基因重排的分析揭示了7种不同的重排,仅在源自同一条细胞系的亚克隆中发现相同的重排。至少使用了3种不同的Vβ基因。具有相同或几乎相同肽特异性、主要组织相容性复合体限制性和同种异体反应性的亚克隆在Vβ或Jβ基因片段利用上可能不同。